FIXING RACK FOR TELECOMMUNICATION APPARATUS AND MOUNTING METHOD THEREOF
    41.
    发明申请
    FIXING RACK FOR TELECOMMUNICATION APPARATUS AND MOUNTING METHOD THEREOF 审中-公开
    固定架用于电信设备及其安装方法

    公开(公告)号:US20110147074A1

    公开(公告)日:2011-06-23

    申请号:US12703839

    申请日:2010-02-11

    IPC分类号: H02B1/40 B23P19/04

    摘要: A fixing rack for a telecommunication apparatus allows the easy mounting, heat dissipation and maintenance of the telecommunication apparatus. A frame of the fixing rack is configured with a second hanging portion, a second joint portion and a fixing portion, wherein the fixing portion fixes the fixing rack on the installation surface, the second hanging portion hangs the telecommunication apparatus on the fixing rack with the first hanging portion configured on the back of the telecommunication apparatus, and the second joint portion joins with the first joint portion of the telecommunication apparatus and fixes the telecommunication apparatus on the fixing rack. The second hanging portion and the first hanging portion allow the telecommunication apparatus to be conveniently mounted onto the fixing rack. The fixing rack generates a gap between the telecommunication apparatus and the installation surface and facilitates heat dissipation and maintenance of the telecommunication apparatus.

    摘要翻译: 用于电信设备的固定架允许电信设备的容易的安装,散热和维护。 固定架的框架具有第二悬挂部分,第二关节部分和固定部分,其中固定部分将固定架固定在安装表面上,第二悬挂部分将电信设备挂在固定架上, 第一悬挂部分,其构造在电信设备的背面,并且第二接合部分与电信设备的第一接合部分连接,并将电信设备固定在固定架上。 第二悬挂部分和第一悬挂部分允许电信设备方便地安装在固定架上。 固定架在电信设备和安装表面之间产生间隙,并促进电信设备的散热和维护。

    ELECTRICAL PROTECTION
    43.
    发明申请
    ELECTRICAL PROTECTION 有权
    电气保护

    公开(公告)号:US20110097912A1

    公开(公告)日:2011-04-28

    申请号:US12620099

    申请日:2009-11-17

    IPC分类号: H01R13/44

    CPC分类号: H01R13/447

    摘要: An electrical protection for mounting on a wire connector housing, wherein the wire connector housing comprises a fixed hole and a plurality of wire-lock apertures exposed on a top surface of the wire connector housing, and the electrical protection comprise an insulating body and an insulating protrusion located at bottom surface of the insulating body. The insulating body is used to cover the wire-lock apertures at the top surface of the wire connector housing, and the insulating protrusion is designed and constructed to fit into the fixed hole of the wire connector housing. The wire-lock apertures of the wire connector housing are all covered and insulated to prevent electrical shock from the electrical leakage through the exposed apertures.

    摘要翻译: 一种用于安装在电线连接器壳体上的电气保护,其中所述电线连接器壳体包括固定孔和暴露在所述电线连接器壳体的顶表面上的多个线锁孔,并且所述电保护包括绝缘体和绝缘体 突起位于绝缘体的底面。 绝缘体用于覆盖电线连接器壳体顶表面处的线锁孔,并且绝缘突起被设计和构造成装配到电线连接器壳体的固定孔中。 电线连接器外壳的线锁孔全部被覆盖和绝缘,以防止通过暴露孔的漏电引起的电击。

    Antiviral helioxanthin analogs
    44.
    发明授权
    Antiviral helioxanthin analogs 有权
    抗病毒螺甲黄素类似物

    公开(公告)号:US07754718B2

    公开(公告)日:2010-07-13

    申请号:US11579284

    申请日:2005-05-02

    IPC分类号: A61K31/502 C07D237/26

    摘要: The present invention relates to novel antiviral helioxanthin analogs. These compounds may particularly be used alone or in combination with other drugs for the treatment of the following: hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus. In addition, compounds according to the present invention can be used to prevent or reduce the likelihood of the occurrence of tumors secondary to virus infection as well as other infections or disease states that are secondary to the virus infection.

    摘要翻译: 本发明涉及新的抗病毒螺甲黄素类似物。 这些化合物可以单独使用或与其他药物组合使用,用于治疗以下物质:肝素病毒,黄病毒,疱疹病毒和人类免疫缺陷病毒。 此外,根据本发明的化合物可用于预防或减少继发于病毒感染的肿瘤以及其它感染或继发于病毒感染的疾病状态的可能性。

    Novel Antiviral Helioxanthin Analogs
    46.
    发明申请
    Novel Antiviral Helioxanthin Analogs 有权
    新型抗病毒Helioxanthin类似物

    公开(公告)号:US20080167353A1

    公开(公告)日:2008-07-10

    申请号:US11579284

    申请日:2005-05-02

    IPC分类号: C07D285/02 A61K31/335

    摘要: The present invention relates to novel antiviral helioxanthin analogs. These compounds may particularly be used alone or in combination with other drugs for the treatment of the following: hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus. In addition, compounds according to the present invention can be used to prevent or reduce the likelihood of the occurrence of tumors secondary to virus infection as well as other infections or disease states that are secondary to the virus infection.

    摘要翻译: 本发明涉及新的抗病毒螺甲黄素类似物。 这些化合物可以单独使用或与其他药物组合使用,用于治疗以下物质:肝素病毒,黄病毒,疱疹病毒和人类免疫缺陷病毒。 此外,根据本发明的化合物可用于预防或减少继发于病毒感染的肿瘤以及其它感染或继发于病毒感染的疾病状态的可能性。

    Novel nucleosides and related processes, pharmaceutical compositions and methods
    48.
    发明申请
    Novel nucleosides and related processes, pharmaceutical compositions and methods 审中-公开
    新型核苷和相关方法,药物组合物和方法

    公开(公告)号:US20050239726A1

    公开(公告)日:2005-10-27

    申请号:US11171181

    申请日:2005-06-30

    CPC分类号: C07H19/22

    摘要: The invention provides novel nucleosides and related processes, pharmaceutical compositions, and methods. The novel nucleosides are useful in a wide variety of antiviral, antineoplastic, and antibacterial applications. Preferred embodiments of the instant invention include novel 2 halogen-substituted, 3 halogen-substituted, and 2′,3′dihalogen-substituted analogues of 3-deazaadenosine, and novel 3 halogen-substituted analogues of 3-deazaguanosine. Compounds of the instant invention, including 4-Amino-6-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine and 6-Amino-7-bromo-1,5-dihydro-1-β-D-ribofuranosylimidazo[4,5-c]pyridin-4-one, have exhibited potent antiviral and anticancer activity in vitro. The compounds are also useful in the concomitant treatment of bacterial infections associated with viral infections such as AIDS.

    摘要翻译: 本发明提供新的核苷和相关方法,药物组合物和方法。 新型核苷可用于各种抗病毒,抗肿瘤和抗菌应用。 本发明的优选实施方案包括3-脱氮腺苷的新的2个卤素取代的3个卤素取代的和2',3'-卤素取代的类似物,以及3-脱氮鸟苷的新的3个卤素取代的类似物。 本发明的化合物包括4-氨基-6-氟-1-(β-D-呋喃核糖基)咪唑并[4,5-c]吡啶和6-氨基-7-溴-1,5-二氢-1- β-吡唑糖基咪唑并[4,5-c]吡啶-4-酮在体外具有很强的抗病毒和抗癌活性。 该化合物也可用于伴随病毒感染如AIDS的细菌感染的治疗。

    L-2',3'-dideoxy nucleoside analogs as anti-Hepatitis B (HBV) agents
    50.
    发明授权
    L-2',3'-dideoxy nucleoside analogs as anti-Hepatitis B (HBV) agents 失效
    L-2',3'-双脱氧核苷类似物作为抗乙型肝炎(HBV)药物

    公开(公告)号:US5631239A

    公开(公告)日:1997-05-20

    申请号:US544650

    申请日:1995-10-18

    摘要: The present invention relates to the surprising discovery that certain dideoxynucleoside analogs which contain a dideoxy ribofuranosyl moiety having an L-configuration (as opposed to the naturally occurring D- configuration) exhibit unexpected activity against Hepatitis B virus (HBV). In particular, the compounds according to the present invention show potent inhibition of the replication of the virus in combination with very low toxicity to the host cells (i.e., animal or human tissue). Compounds according to the present invention exhibit primary utility as agents for inhibiting the growth or replication of HBV, HIV and other retroviruses, most preferably HBV.

    摘要翻译: 本发明涉及令​​人惊奇的发现,含有具有L-构型的双脱氧呋喃核糖基部分(与天然存在的D-构型相反)的某些双脱氧核苷类似物对乙型肝炎病毒(HBV)表现出意想不到的活性。 特别地,根据本发明的化合物显示了对宿主细胞(即动物或人体组织)的非常低毒性的复制的有效抑制。 根据本发明的化合物显示出用于抑制HBV,HIV和其他逆转录病毒生长或复制的药剂的主要用途,最优选为HBV。